Miranda Broz, PhD is the Scientific Associate Director of Discovery Myeloid Biology at Bristol Myers Squibb’s R&D site in Redwood City, California. Miranda and her team explores parts of the tumor microenvironment (TME) - including regulatory T cells, stromal cells and myeloid antigen presenting cells - to develop novel treatment options that will benefit patients with difficult-to-treat cancers. In this episode, Miranda shares her journey from PhD to Scientific Officer at Pionyr Immunotherapeutics - an immuno-oncology focused startup that was founded based on her thesis work at UCSF - to her current role at Bristol Myers Squibb. We discuss the various learning curves that she scaled as a growing industry scientist, the skills that she developed in order to effectively lead teams through pre-clinical drug development, and the enriching institutional support that Bristol Myers Squibb offers its employees. Furthermore, we briefly discuss the history of cancer immunotherapies as the field has matured over the past few decades, the challenges that still exist for the field, and the approach that Miranda & her colleagues are taking to overcome those challenges. Hosted by Roshan Chikarmane and Jenna Glatzer.